Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein, Inc. reports developments across its health care distribution, practice solutions, and dental technology businesses. The company serves office-based dental and medical practitioners, dental laboratories, government and institutional health care clinics, and other alternate care sites through business, clinical, technology, and supply chain solutions.
Recurring news themes include earnings releases, financial guidance, investor conference participation, board and executive governance updates, and product announcements from Henry Schein One. Recent technology coverage centers on Dentrix Ascend, a cloud-based dental platform that integrates practice management, clinical workflows, imaging, revenue cycle management, analytics, patient experience tools, and AI-enabled workflow capabilities.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Henry Schein, Inc. (Nasdaq: HSIC) will announce its Q1 2023 financial results on May 9, 2023, before the market opens. The earnings conference call is set for 10:00 a.m. Eastern time, featuring CEO Stanley M. Bergman and CFO Ronald N. South. Investors can access the live webcast at www.henryschein.com/IRwebcasts.
Henry Schein is the largest provider of health care solutions for dental and medical practitioners, serving over 1 million customers with more than 300 solutions. The company, headquartered in Melville, N.Y., reported $12.6 billion in sales in 2022 and operates in 32 countries. For more information, visit www.henryschein.com.